BNTX
NASDAQ
DE
BioNTech SE - American Depositary Shares
$91.18
▲ +$1.76
(+1.97%)
Vol 787K
7
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$22.9B
ROE
-3.0%
Margin
8.5%
D/E
1.33
Beta
1.51
52W
$81–$129
Wall Street Consensus
27 analysts · Apr 20266
Strong Buy
15
Buy
6
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 80.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.19 | $-1.25 | $-1.06 |
| Sep 2025 | $-0.22 | $-0.12 | +$0.10 |
| Jun 2025 | $-2.05 | $-1.60 | +$0.45 |
| Mar 2025 | $-2.13 | $-1.73 | +$0.40 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $1.2B | $182.8M | $260.8M | $1.5B | $907.4M |
| Net Income | — | $259.5M | -$415.8M | -$386.6M | -$28.7M | -$305.0M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -1.8% | -1.8% | -1.8% | -1.8% | -3.0% | -3.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -24.2% | -24.2% | -24.2% | 8.5% | 8.5% |
| Gross Margin | — | 84.9% | 84.9% | 84.9% | 86.8% | 86.8% |
| D/E Ratio | 1.46 | 1.46 | 1.46 | 1.46 | 1.33 | 1.33 |
| Current Ratio | 8.61 | 8.61 | 8.61 | 8.61 | 7.12 | 7.12 |
Key Ratios
ROA (TTM)
-2.6%
P/S (TTM)
7.20
P/B
1.2
EPS (TTM)
$-2.36
CF/Share
$13.01
Rev Growth 3Y
-47.5%
52W High
$129.27
52W Low
$81.20
$81.20
52-Week Range
$129.27
Financial Health
Free Cash Flow
$247.4M
Net Debt
-$7.4B
Cash
$7.7B
Total Debt
$267.4M
As of Dec 31, 2025
How does BNTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
BNTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
7.2
▼
44%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.2
▼
51%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
BNTX profitability vs Biotechnology peers
ROE
-3.0%
▲
95%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
8.5%
▲
103%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
86.8%
▲
10%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-2.6%
▲
94%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
BNTX financial health vs Biotechnology peers
D/E ratio
1.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
7.1
▲
60%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
1.5
▲
55%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
BNTX fundamentals radar
BNTX
Peer median
Industry
BNTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
BNTX vs peers: key metrics
Related Signals
Latest AI Opinion
Grok
SKIP
Price action shows a sharp plunge to a low of $79.52 on March 9, 2026, with massive volume (21.8M shares), followed by a partial recovery to $90.86, but no clear upward momentum or higher lows yet, making this a risky …
Mar 23, 2026Top Holders
Top 5: 9.18%FMR, LLC
2.47%
$508.4M
T. Rowe Price Investment Ma…
1.87%
$384.2M
Flossbach von Storch SE
1.75%
$359.5M
Primecap Management Company
1.58%
$325.6M
Dodge & Cox Inc.
1.51%
$309.7M
As of Dec 31, 2025
Dividends
$2.11
/ year
Jun 02, 2022
$2.1110